PD1 and LAG3 have been reported as the most prevalent T-cell immune checkpoint receptors in RCC, and their blockade to increase IFNγ signaling was considered crucial for successful anti-cancer immunosurveillance [44]. The gene discussed is IFNG; the disease is cancer.